News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Valeant Pharmaceuticals International
NEWS
IN THE PRESS
NEWS
Valeant Pharmaceuticals International was acquired by Bausch & Lomb in 2013.
Valeant Management Tells The Future, If You Care To Listen
May 5, 2017
·
1 min read
Embattled Valeant Mulls Over Name Change For A Fresh Start
May 3, 2017
·
1 min read
Business
Valeant Plummets After Revealing Jaw-Dropping Payday for Its CEO
April 5, 2017
·
2 min read
Business
Why Bill Ackman Really Left Valeant
April 5, 2017
·
2 min read
Policy
Valeant’s Ex-CEO Sues Company Over Alleged Unpaid Shares
March 28, 2017
·
1 min read
BioMidwest
These Two Drugmakers Have Even More Debt Than Valeant
March 27, 2017
·
2 min read
Valeant: Damaged Goods Or A Deeply Discounted Drug Company?
March 24, 2017
·
1 min read
Business
Embattled Valeant’s New CEO Took Home $62.7 Million Last Year
March 24, 2017
·
1 min read
Business
Does Ackman’s Exit Finally Signal A Bottom For Valeant?
March 21, 2017
·
1 min read
IN THE PRESS
Bausch + Lomb Begins Distribution of VYZULTA (Latanoprostene Bunod Ophthalmic Solution), 0.024% to U.S. Wholesalers
December 18, 2017
·
3 min read
Valeant and One of Its Subsidiaries Announce Early Tender Results and Early Settlement Date on December 18 for Cash Tender Offers for Senior Notes
December 15, 2017
·
9 min read
Valeant Pharmaceuticals Announces Pricing of Private Offering of Senior Notes
December 4, 2017
·
4 min read
Valeant Pharma and One of its Subsidiaries Commence Cash Tender Offers for Up to $1,000,000,000 Outstanding Principal Amount
December 4, 2017
·
12 min read
Valeant Pharma Announces Launch of Private Offering of Senior Notes
December 4, 2017
·
3 min read
Valeant Announces Closing of Add-On Secured Notes and Credit Agreement Amendment
November 21, 2017
·
1 min read
Bausch & Lomb Helps to Recycle More Than One Million Units of Contact Lens Materials Within First Year of Launching the ONE by ONE Recycling Program
November 15, 2017
·
4 min read
Valeant Announces Pricing of Private Offering of Add-on Secured Notes
November 14, 2017
·
4 min read
Policy
Argentum Pharma Succeeds in Starting Patent Cancellation Trial Against Valeant’s JUBLIA
November 13, 2017
·
1 min read
Valeant Announces Launch of Private Offering of Add-on Secured Notes
November 13, 2017
·
3 min read